Cargando…
Characterization of the SARS-CoV-2 coronavirus X4-like accessory protein
BACKGROUND: The novel coronavirus SARS-CoV-2 is currently a global threat to health and economies. Therapeutics and vaccines are in rapid development; however, none of these therapeutics are considered as absolute cure, and the potential to mutate makes it necessary to find therapeutics that target...
Autores principales: | Durojaye, Olanrewaju Ayodeji, Okoro, Nkwachukwu Oziamara, Odiba, Arome Solomon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105150/ http://dx.doi.org/10.1186/s43042-021-00160-1 |
Ejemplares similares
-
MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2023) -
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders
por: Odiba, Arome Solomon, et al.
Publicado: (2021) -
Polysaccharides Extracted from Dendrobium officinale Grown in Different Environments Elicit Varying Health Benefits in Caenorhabditis elegans
por: Okoro, Nkwachukwu Oziamara, et al.
Publicado: (2023) -
FTO gene expression in diet-induced obesity is downregulated by Solanum fruit supplementation
por: Asuquo, Edeke Affiong, et al.
Publicado: (2022) -
Bioactive Phytochemicals with Anti-Aging and Lifespan Extending Potentials in Caenorhabditis elegans
por: Okoro, Nkwachukwu Oziamara, et al.
Publicado: (2021)